Validose

Brooklyn, NY · Founded 2017 · Privately Held (backing)

Developer of an intranasal drug delivery platform designed to deliver medication adherence solutions for clinical trials in real-time. Validose is based in Brooklyn, NY and was founded in 2017. It was valued at $6 million at its seed round in Jan 2025, the last priced event on record. It has raised $2 million across 1 recorded round; the latest was a $1.6 million seed round in Dec 2024.

PMV mark · valuation
$6.0M
Oct 2026
Priced at
its seed round
Jan 2025
Total raised
$2.0M
Last round
Seed Round
Dec 2024

Who backs Validose?

3 investors
InvestorType
Interstate Fusion VenturesVenture capital
Bauer Family Office's Technology for HumanityVenture capital
10XBetaVenture capital
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Validose investors

3 investors are on record for Validose, including Interstate Fusion Ventures, Bauer Family Office's Technology for Humanity and 10XBeta. By type, the record holds 3 venture capital firms. The seed round in Dec 2024 drew 2 investors.

Free account
More of Validose with a free account
  • ·Watch Validose: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 3 firms already write checks for companies like Validose. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View